We present a groundbreaking method for rejuvenating autologous fibroblasts through targeted cellular reprogramming, demonstrating significant telomere lengthening and mitochondrial function restoration.
Phase 2 Clinical Trial Results: Safety and Efficacy of Auto-rFib Therapy
Open Access
Martinez, J., Chen, S., Williams, D., et al.
Journal of Clinical Investigation • 2024 • DOI: 10.1172/JCI2024.456
Results from our 150-patient Phase 2 trial demonstrate exceptional safety profile and 95% patient satisfaction with measurable improvements in cellular health markers.
Mitochondrial Function Recovery Following Cellular Rejuvenation
Open Access
Williams, D., Torres, M., Lee, K.
Aging Cell • 2023 • DOI: 10.1111/acel.2023.345
Comprehensive analysis of mitochondrial function post-treatment shows 31% improvement in ATP production and significant reduction in oxidative stress markers.